|
ZNHIT6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.870600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.854200E-02 |
| Normal-vs-Stage2 |
2.894800E-01 |
| Normal-vs-Stage3 |
2.297800E-01 |
| Normal-vs-Stage4 |
4.274600E-01 |
| Stage1-vs-Stage2 |
9.904200E-01 |
| Stage1-vs-Stage3 |
4.238400E-02 |
| Stage1-vs-Stage4 |
7.125900E-02 |
| Stage2-vs-Stage3 |
8.069700E-02 |
| Stage2-vs-Stage4 |
1.525560E-01 |
| Stage3-vs-Stage4 |
9.391600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.161600E-01 |
| Normal-vs-AfricanAmerican |
2.907600E-01 |
| Normal-vs-Asian |
3.636600E-01 |
| Caucasian-vs-AfricanAmerican |
7.440400E-01 |
| Caucasian-vs-Asian |
2.979200E-01 |
| AfricanAmerican-vs-Asian |
2.801400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.189500E-02 |
| Normal-vs-Female |
3.258200E-02 |
| Male-vs-Female |
5.76219999999239E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.086400E-01 |
| Normal-vs-Extreme_Weight |
2.236300E-02 |
| Normal-vs-Obese |
7.910000E-01 |
| Normal-vs-Extreme_Obese |
2.684400E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.984600E-01 |
| Normal_Weight-vs-Obese |
3.600600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.124800E-01 |
| Extreme_Weight-vs-Obese |
3.531500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.833600E-01 |
| Obese-vs-Extreme_Obese |
3.793700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.596400E-02 |
| Normal-vs-Age(41-60Yrs) |
8.994400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.150000E-02 |
| Normal-vs-Age(81-100Yrs) |
2.775200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.981900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.753720E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.538000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.468100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.884300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.297600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.580400E-02 |
| Normal-VS-Type2 PRCC |
1.943380E-01 |
| Normal-VS-KIRP CIMP |
1.220000E-02 |
| Normal-VS-Unclassified PRCC |
4.643400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.746200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.440400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.659700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.220600E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.070620E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.290360E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.439020E-03 |
| Normal-vs-N1 |
1.216200E-02 |
| Normal-vs-N2 |
8.891400E-01 |
| N0-vs-N1 |
3.152400E-04 |
| N0-vs-N2 |
4.713400E-01 |
| N1-vs-N2 |
3.485000E-01 |
|
|
